projectssite.blogg.se - Chromium chloride with amla and shilajit

CHROMIUM CHLORIDE WITH AMLA AND SHILAJIT PDF

A61K2300/00- Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00Įndothelial dysfunction, present at disease onset, may be the cause of atherogenesis that is present throughout the course of DM and associated with late-stage adverse outcomes (Panwar, et al., “Atherothrombotic risk factors & premature coronary heart disease in India: A case-control study,” Indian J.A61P3/10- Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g.A61P3/08- Drugs for disorders of the metabolism for glucose homeostasis.A61P3/00- Drugs for disorders of the metabolism.A61P- SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS.A61K36/47- Euphorbiaceae (Spurge family), e.g.A61K36/185- Magnoliopsida (dicotyledons).

A61K36/00- Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g.

A61K35/04- Tars Bitumens Mineral oils Ammonium bituminosulfonate.

A61K35/02- Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials.

A61K35/00- Medicinal preparations containing materials or reaction products thereof with undetermined constitution.

A61K33/24- Heavy metals Compounds thereof.

A61K33/00- Medicinal preparations containing inorganic active ingredients.

A61K31/366- Lactones having six-membered rings, e.g.

A61K31/335- Heterocyclic compounds having oxygen as the only ring hetero atom, e.g.

valproic acid having two or more carboxyl groups, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids

A61K31/185- Acids Anhydrides, halides or salts thereof, e.g.

A61K31/00- Medicinal preparations containing organic active ingredients.

A61K- PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES.

A61- MEDICAL OR VETERINARY SCIENCE HYGIENE.

Assignors: KALIDINDI, SANYASI R Status Active legal-status Critical Current Anticipated expiration legal-status Critical Links ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: KALIDINDI, SANYASI R Application granted granted Critical Publication of US10183047B2 publication Critical patent/US10183047B2/en Assigned to NATREON, INC.

Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Priority claimed from US201462001438P external-priority Priority claimed from US14/718,613 external-priority patent/US20160015740A1/en Application filed by Natreon Inc filed Critical Natreon Inc Priority to US14/947,987 priority Critical patent/US10183047B2/en Publication of US20160074452A1 publication Critical patent/US20160074452A1/en Assigned to NATREON, INC. Original Assignee Natreon Inc Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.) Kalidindi Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.) Active Application number US14/947,987 Other versions US20160074452A1

CHROMIUM CHLORIDE WITH AMLA AND SHILAJIT PDF

Google Patents Chromium-containing compositions in combination with Phyllanthus emblica and shilajit having synergistic effects for improving endothelial function and cardiovascular healthĭownload PDF Info Publication number US10183047B2 US10183047B2 US14/947,987 US201514947987A US10183047B2 US 10183047 B2 US10183047 B2 US 10183047B2 US 201514947987 A US201514947987 A US 201514947987A US 10183047 B2 US10183047 B2 US 10183047B2 Authority US United States Prior art keywords mcg chromium shilajit crominex phyllanthus emblica Prior art date Legal status (The legal status is an assumption and is not a legal conclusion. Google Patents US10183047B2 - Chromium-containing compositions in combination with Phyllanthus emblica and shilajit having synergistic effects for improving endothelial function and cardiovascular health US10183047B2 - Chromium-containing compositions in combination with Phyllanthus emblica and shilajit having synergistic effects for improving endothelial function and cardiovascular health